| |
| |
|
| Insider
Information: |
Nicolette Charles A. |
| Relationship: |
CSO and Vice President... |
| City: |
Durham |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
20,056 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,074 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
20,056 |
|
|
| Total
Value |
$1,074 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Argos Therapeutics Inc |
ARGS |
CSO and Vice President... |
2018-04-25 |
20,056 |
2014-02-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARGS |
Argos Therapeutics Inc |
CSO and Vice President of R&D |
• – – |
2018-04-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(27,150) |
20,056 |
0 |
- |
|
| ARGS |
Argos Therapeutics Inc |
CSO and Vice President of R&D |
• – – |
2018-03-28 |
4 |
A |
$0.00 |
$0 |
D/D |
27,150 |
47,206 |
0 |
- |
|
| ARGS |
Argos Therapeutics Inc |
CSO and Vice President of R&D |
• – – |
2018-01-10 |
4/A |
AS |
$0.16 |
$16,501 |
D/D |
(100,250) |
399,990 |
0 |
- |
|
| ARGS |
Argos Therapeutics Inc |
CSO and Vice President of R&D |
• – – |
2018-01-09 |
4 |
AS |
$0.16 |
$16,501 |
D/D |
(100,250) |
399,990 |
0 |
- |
|
| ARGS |
Argos Therapeutics Inc |
CSO and Vice President of R&D |
• – – |
2018-01-03 |
4 |
AS |
$0.16 |
$15,061 |
D/D |
(92,001) |
500,240 |
0 |
- |
|
| ARGS |
Argos Therapeutics Inc |
Chief Science Officer |
• – – |
2017-08-30 |
4 |
A |
$0.00 |
$0 |
D/D |
499,445 |
592,241 |
0 |
- |
|
| ARGS |
Argos Therapeutics Inc |
Chief Science Officer |
• – – |
2017-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
16,753 |
92,796 |
0 |
- |
|
| ARGS |
Argos Therapeutics Inc |
Chief Scientific Officer |
• – – |
2016-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
10,924 |
76,043 |
0 |
- |
|
| ARGS |
Argos Therapeutics Inc |
Chief Scientific Officer |
• – – |
2016-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
48,604 |
63,117 |
0 |
- |
|
| ARGS |
Argos Therapeutics Inc |
Chief Scientific Officer |
• – – |
2015-08-20 |
4 |
B |
$6.45 |
$32,250 |
D/D |
5,000 |
13,130 |
2.74 |
- |
|
| ARGS |
Argos Therapeutics Inc |
CSO |
• – – |
2014-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
6,800 |
6,800 |
0 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
